Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
Journal of Urology | April 7, 2023 | Volume: 209 | Issue: 5 | Pages: 890-900
10.1097/ju.0000000000003195
| PMID 37026631